EC Number   |
Application |
Reference |
|---|
    5.1.99.4 | analysis |
fluorescent enzyme-linked aptamer assay for alpha-methylacyl-CoA racemase. The assay shows a dynamic range from 0.1 to 1000 nM of AMACR, a low detection limit of 0.44 nM (19.5 ng/ml), and high AMACR specificity |
747334 |
| 5.1.99.4 | diagnostics |
AMACR is established as a valuable diagnostic marker for prostate cancer and has shown to be useful in the diagnosis of colorectal carcinoma |
704836 |
| 5.1.99.4 | diagnostics |
biomarker for cancer in prostate, breast, colon, renal and other cancer cells |
706046 |
| 5.1.99.4 | diagnostics |
combined AMACR/p53 analysis to identify dysplasia in inflammatory bowel disease like ulcerative colitis and Crohns disease |
703973 |
| 5.1.99.4 | diagnostics |
cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens |
701605 |
| 5.1.99.4 | diagnostics |
the elevated expression of the P504S gene and its enzyme product can serve as a molecular marker for prostate cancer |
703387 |
| 5.1.99.4 | diagnostics |
the enzyme can be used as a marker in the differential diagnosis of metanephric adenoma and as a molecular marker for prostate carcinoma |
681814 |
| 5.1.99.4 | diagnostics |
the enzyme is a biomarker overexpressed in prostate carcinomas and is associated with prostate cancer progression |
680093 |
| 5.1.99.4 | diagnostics |
the enzyme is a marker for prostate and renal cancer |
680089 |
| 5.1.99.4 | diagnostics |
the enzyme is a sensitive and specific biomarker for the diagnosis of prostate cancer |
682625 |
